Skybiotech Healthcare (BOM:512036) LT-Debt-to-Total-Asset: 0.42 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:512036 Skybiotech Healthcare Ltd BOM:512036
23 GF Score
Price ₹148.95
! 4 Warning Signs
View Full Analysis

What is Skybiotech Healthcare LT-Debt-to-Total-Asset?

Skybiotech Healthcare BOM:512036 -0.30% 23 LT-Debt-to-Total-Asset is 0.42 as of Mar. 2026. GuruFocus rates BOM:512036 with a GF Score™ of 23/100. The stock has 4 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Skybiotech Healthcare's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.42.

Skybiotech Healthcare's long-term debt to total assets ratio increased from Mar. 2025 (0.35) to Mar. 2026 (0.42). It may suggest that Skybiotech Healthcare is progressively becoming more dependent on debt to grow their business.

Skybiotech Healthcare  (BOM:512036) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Skybiotech Healthcare LT-Debt-to-Total-Asset Related Terms

Skybiotech Healthcare LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Skybiotech Healthcare's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skybiotech Healthcare LT-Debt-to-Total-Asset Chart

Skybiotech Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.35 0.42

Skybiotech Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.00 0.36 0.00 0.42
BOM:512036
23GF Score
Skybiotech Healthcare Ltd BOM:512036
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Skybiotech Healthcare LT-Debt-to-Total-Asset Calculation

Skybiotech Healthcare's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )/Total Assets (A: Mar. 2026 )
=82.485/194.407
=0.42

Skybiotech Healthcare's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=82.485/194.407
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.42 mean?
Skybiotech Healthcare (BOM:512036) has a LT-Debt-to-Total-Asset of 0.42 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Skybiotech Healthcare and its competitors.
Is Skybiotech Healthcare's LT-Debt-to-Total-Asset too high?
Skybiotech Healthcare's current LT-Debt-to-Total-Asset is 0.42. Overall, Skybiotech Healthcare has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Skybiotech Healthcare's LT-Debt-to-Total-Asset compare to MMM and HON?
Skybiotech Healthcare's LT-Debt-to-Total-Asset of 0.42 can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Conglomerates company?
A good LT-Debt-to-Total-Asset depends on the Conglomerates industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Skybiotech Healthcare and its competitors. Skybiotech Healthcare's current LT-Debt-to-Total-Asset is 0.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skybiotech Healthcare stock overvalued right now?
Skybiotech Healthcare (BOM:512036) has a current LT-Debt-to-Total-Asset of 0.42. The current LT-Debt-to-Total-Asset is 0.42. Skybiotech Healthcare's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Skybiotech Healthcare (BOM:512036), the current LT-Debt-to-Total-Asset is 0.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skybiotech Healthcare Business Description

Address Paithan Road, Gevrai Tanda, Gut No. 05, Chhatrapati Sambhaji Nagar, MH, IND, 431002
Skybiotech Healthcare Ltd, formerly Kapil Cotex Ltd is engaged in textiles and allied products, including dyeing, printing, spinning, weaving, and manufacturing fabrics from raw cotton. During the year under review, the company has not generated any revenue from its core business activities. Instead, it earned income from consultancy services for foreign clients and from investments in shares, generating capital gains and dividends. The company's current revenue mainly comes from these non-core activities rather than textile manufacturing.
23GF Score

Get the complete analysis for BOM:512036

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹148.95
Price